Cardia 7 - Omega 7 Fatty Acids Pharmaceutical Grade - 30 Softgels
Cardia 7 is the result of years of scientific research to develop a pharmaceutical grade Omega 7 product with the intent to raise HDL ("good") cholesterol levels and promote a healthy response to inflammation. 100% natural, Omega 7 has shown the potential in clinical studies to raise "good" cholesterol levels without the flushing associated with niacin. Combining a healthy diet, exercise and Cardia 7 capsules are great steps in your efforts for a healthy heart.
The Heartier Omega
Introducing Omega 7 (Palmitoleic Acid)
Not all Fatty Acids are created equal. That’s why they created Cardia 7 Omega 7 with Provinal Fatty Acids, with "More of the good and less of the bad." Research has shown that Palmitoleic Acid, which is completely natural, and derived from the Omega 7 family of fatty acids, can simultaneously increase good cholesterol, lower bad cholesterol, and lower triglycerides. It is completely natural, with no side effects.
The Heartier Benefits of Omega 7:
- Increases HDLs (good cholesterol)
- Lowers LDLs (bad cholesterol)
- Lowers Triglycerides
- Reduces Inflammation
- Reduces buildup of Atherosclerotic Plaque
In initial human tests, a daily regimen of Omega 7 (Palmitoleic Acid) has helped increase HDLs (good cholesterol) by 17%. Having a higher HDL places one into a lower risk category of subsequent heart attacks or other cardiosvacular-related complications. "Think of HDL as the garbage trucks of the bloodstream. HDL cholesterol is often referred to as good, or protective, cholesterol."
"More of the Good and Less of the Bad"
One of the "toxins" many people consume every day comes in the form of palmitic acid they ingest whenever they eat foods containing saturated fats (meats, cheeses, dairy). Palmitic acid has been shown to increase insulin resistance, kill beta cells in the pancreas, and turn the switch off that tells you when you’re full. On the other hand, palmitoleic acid has been shown to increase insulin sensitivity by suppressing inflammation…. as well as inhibit the destruction of beta cells caused by saturates. So in order to reduce the amount of toxins in our body, everyone should: (1) reduce intake of saturated fats in your diet, and (2) take a supplement rich in palmitoleic acid.
Why Cardia 7 is better than Sea Buckthorn
While there are current formulations of Omega 7 on the market they should not be confused with Cardia 7. The concentration of Palmitic Acid from sea buckthorn sources contains upwards of 40% of Palmitic Acid, which actually exceeds the concentration in those preparations of the "good fatty acid", Palmitoleic Acid.
The concentration of Palmitic Acid in Cardia 7 is currently limited to less than 2%. Cardia 7 is the best source for Omega 7 on the market because Provinal is 40% Ultrapurified Omega 7 (palmitoleic acid), and they’ve taken great pains to remove the palmitic acid. Hence "more of the good" and "less (virtually none) of the bad".
A Research Comparative of Fatty Acids – EPA and Palmitoleic Acid
Palmitoleic Acid (PA) Outperforms EPA in Identical KK-A? Mouse Study Regarding Effects on Triglyceride Levels and Weight Gain
Research on Palmitoleic acid sponsored by Nippon Suisan Kaisha at the Central Research Laboratory in Japan as compared to identical research model published through a joint collaboration of research scientists at the Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan and the Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
- EPA – Eicosapentaenoic acid (EPA) has been reported to have beneficial effects on the progression of various renal diseases including diabetic nephropathy; however, the precise mechanisms are not completely understood. The joint collaboration examined the effects of EPA on the early stage of type 2 diabetic nephropathy in KK-A? mice and the possible role of inflammation, oxidative stress, and growth factor in this process.
- PA – Palmitoleic Acid Studies have demonstrated the beneficial effect of palmitoleic acid (C16:1 n-7) on reducing muscle insulin resistance and preventing beta-cell apoptosis. However, the effect of palmitoleic acid on diabetes remains to be elucidated. The aim of this study was to examine the antidiabetic effect of palmitoleic acid in KK-A? mice, a spontaneous model for studies of obese type 2 diabetes with low insulin sensitivity.
- EPA – The treatment group was injected with EPA ethyl ester (Epadel from Mochida – a compound licensed by Amarin with the FDA) at 1 g/kg per day intraperitoneally from 12 to 20 weeks of age and the control group was injected with saline. Renal morphologic examinations were performed after 8 weeks of treatment.
- PA – KK-A? mice were orally administered 300 mg/kg of palmitoleic acid or 300 mg/kg of palmitic acid (C16:0) on a daily basis for 4 weeks and compared vs. control.
After 8 weeks, the EPA dosage of 45 mg daily reduced TG levels in the mice by approximately 44%, while after just 4 weeks the Palmitoleic Acid dosage of 9 mg daily reduced TG levels by approximately 50%. Additionally, the mice administered with palmitoleic acid showed a reduction in body weight increase while those administered with EPA showed no impact on body weight increase. TG levels are expressed in the chart below in mg/dL.
Conclusions & Implications:
At five fold less dosage, in identical animal models, with the same power estimates statistically (similar N’s = 8 & 10 animals tested) Palmitoleic Acid demonstrates very similar to superior effects to those of EPA. Therefore, the data supports that C16:1 ethyl ester is of greater potency than EPA on TG and insulin-like effects in identical mouse animal models.